Tajikistan: How MSF’s Zero TB project in Kulob is transforming the fight against tuberculosis
January 28, 2026In southern Tajikistan’s Kulob region, Médecins Sans Frontières (MSF) is bringing screening, diagnosis, and support for tuberculosis (TB) directly into communities.TB is a curable disease, yet many people are diagnosed late due to limited access to healthcare services, lack of...
Read more
MSF IMPACT: MSF Integrated Medical, Psychosocial, And Capacity Building TB Unit
November 19, 2025MSF in South Asia: Projects in South Asia Access campaign Connect with us What We Do The MSF Training Unit is committed to strengthening local capacity and resilience in TB control, with a particular focus on addressing drug-resistant TB (DR-TB)....
Read more
Global Fund crisis threatens progress against HIV, TB, Malaria
November 17, 2025MSF Warns: Pending Global Fund Replenishment Crisis Threatens Decades of Progress Against HIV, TB, and Malaria.Investments Must Be Sustained to Prevent Catastrophic Cuts and Soaring Patient CostsNovember 17th, 2025: Ahead of the Global Fund’s Eighth Replenishment Summit in Johannesburg, Doctors...
Read more
MSF and partners make a real difference for tuberculosis patients in Iraq
October 20, 2025Umm Salam* sits on the ground outside her family’s home in Sadr City, a crowded district of Iraq’s capital, Baghdad. She holds her granddaughter, Zainab*, close, wrapped in her abaya, recalling the young girl’s recovery from tuberculosis (TB).As part of...
Read more
Uzbekistan: MSF Successfully Concludes Nukus TB Project
September 23, 2025Nukus/ Amsterdam, 22 September 2025 – Médecins Sans Frontières (MSF), the Ministry of Health of Uzbekistan (MoH) and the Ministry of Health of Karakalpakstan today marked the successful conclusion of their long-running collaboration on the Karakalpakstan Tuberculosis Programme. The closing...
Read more
Early Results of First Trial Conducted Exclusively in People with Pre-Extensively Drug-Resistant Tuberculosis Show Promise
August 1, 2025Paris/Boston, 13 November 2024 - The endTB consortium has completed endTB-Q, the first Phase 3 randomized controlled trial to exclusively enroll people suffering from pre-extensively drug-resistant tuberculosis (pre-XDR-TB), a very hard-to-treat form of tuberculosis (TB). The trial, conducted by the endTB...
Read more
From innovation to action: MSF shares 25 years of lessons learned in tackling Drug-Resistant TB
January 22, 2025January 22, 2025, New Delhi: Médecins Sans Frontières (MSF)/Doctors Without Borders, in partnership with the National TB Elimination Program (NTEP) and the Brihanmumbai Municipal Corporation (BMC), hosted a panel discussion today to mark the culmination of 25 years of continuous...
Read more
After 18 years, MSF hands over its Drug-Resistant Tuberculosis (DR-TB) Project to the National TB Elimination Program in Mumbai
September 27, 202427 Sept 2024, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders today announced the planned closure of its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project by the end of 2024. This significant initiative has been providing comprehensive care to patients with complex cases...
Read more
India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
June 11, 202410 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the...
Read more
India: How Deepak Shegar overcame DR-TB to reclaim his dreams
June 10, 2024Mumbai, India- "When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and...
Read more
Deepak Shegar: Battling DR-TB with resilience and dreams
June 10, 2024"When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire...
Read more
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read more
